Cargando…
In vivo Anti‐tumor Activity of a Novel Indolocarbazole Compound, J‐107088, on Murine and Human Tumors Transplanted into Mice
J‐107088 (6‐N‐(1‐hydroxymethyl‐2‐hydroxy)ethylamino‐12,13‐dihydro‐2,10‐dihydroxy‐13‐(β‐D‐glu‐copyranosyl)‐5H‐indolo[2,3‐a]‐pyrrolo [3,4‐c]carbazole‐5,7(6H)‐dione) is a derivative of NB‐506, an indolocarbazole compound previously reported as an anti‐tumor agent targeting topoisomerase L The optimal a...
Autores principales: | Arakawa, Hiroharu, Morita, Masashi, Kodera, Tsutomu, Okura, Akira, Ohkubo, Mitsuru, Morishima, Hajime, Nishimura, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925996/ https://www.ncbi.nlm.nih.gov/pubmed/10595746 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00691.x |
Ejemplares similares
-
Antimetastatic Effect of a Novel Indolocarbazole (NB‐506) on IMC‐HM Murine Tumor Cells Metastasized to the Liver
por: Arakawa, Hiroharu, et al.
Publicado: (1996) -
ED‐110, a Novel Indolocarbazole, Prevents the Growth of Experimental Tumors in Mice
por: Arakawa, Hiroharu, et al.
Publicado: (1993) -
Stereo(C7)‐dependent Topoisomerase II Inhibition and Tumor Growth Suppression by a New Quinolone, BO‐2367
por: Yoshinari, Tomoko, et al.
Publicado: (1993) -
Antikinetoplastid Activity of Indolocarbazoles from Streptomyces sanyensis
por: Cartuche, Luis, et al.
Publicado: (2020) -
Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells
por: Sun, Yuan, et al.
Publicado: (2011)